152 related articles for article (PubMed ID: 38713486)
1. A CARM1 Inhibitor Potently Suppresses Breast Cancer Both In Vitro and In Vivo.
Peng BL; Ran T; Chen X; Ding JC; Wang ZR; Li WJ; Liu W
J Med Chem; 2024 May; 67(10):7921-7934. PubMed ID: 38713486
[TBL] [Abstract][Full Text] [Related]
2. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
3. Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma.
Liu Z; Lin M; Liu C; Chen X; Chen Q; Li X; Wu X; Wang Y; Wang L; Yang F; Luo C; Jin J; Ye F
J Med Chem; 2024 Apr; 67(8):6313-6326. PubMed ID: 38574345
[TBL] [Abstract][Full Text] [Related]
4. A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.
Cai XC; Zhang T; Kim EJ; Jiang M; Wang K; Wang J; Chen S; Zhang N; Wu H; Li F; Dela Seña CC; Zeng H; Vivcharuk V; Niu X; Zheng W; Lee JP; Chen Y; Barsyte D; Szewczyk M; Hajian T; Ibáñez G; Dong A; Dombrovski L; Zhang Z; Deng H; Min J; Arrowsmith CH; Mazutis L; Shi L; Vedadi M; Brown PJ; Xiang J; Qin LX; Xu W; Luo M
Elife; 2019 Oct; 8():. PubMed ID: 31657716
[TBL] [Abstract][Full Text] [Related]
5. PELP1 oncogenic functions involve CARM1 regulation.
Mann M; Cortez V; Vadlamudi R
Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
[TBL] [Abstract][Full Text] [Related]
6. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W
Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336
[TBL] [Abstract][Full Text] [Related]
7. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.
Frietze S; Lupien M; Silver PA; Brown M
Cancer Res; 2008 Jan; 68(1):301-6. PubMed ID: 18172323
[TBL] [Abstract][Full Text] [Related]
8. Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1.
Ran T; Li W; Peng B; Xie B; Lu T; Lu S; Liu W
J Chem Inf Model; 2019 Jan; 59(1):522-534. PubMed ID: 30607947
[TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Inhibitors against Coactivator Associated Arginine Methyltransferase 1 Based on Virtual Screening and Biological Assays.
Ye F; Zhang W; Lu W; Xie Y; Jiang H; Jin J; Luo C
Biomed Res Int; 2016; 2016():7086390. PubMed ID: 27872854
[TBL] [Abstract][Full Text] [Related]
10. Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition.
Shishkova E; Zeng H; Liu F; Kwiecien NW; Hebert AS; Coon JJ; Xu W
Nat Commun; 2017 May; 8():15571. PubMed ID: 28537268
[TBL] [Abstract][Full Text] [Related]
11. Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma.
Drew AE; Moradei O; Jacques SL; Rioux N; Boriack-Sjodin AP; Allain C; Scott MP; Jin L; Raimondi A; Handler JL; Ott HM; Kruger RG; McCabe MT; Sneeringer C; Riera T; Shapiro G; Waters NJ; Mitchell LH; Duncan KW; Moyer MP; Copeland RA; Smith J; Chesworth R; Ribich SA
Sci Rep; 2017 Dec; 7(1):17993. PubMed ID: 29269946
[TBL] [Abstract][Full Text] [Related]
12. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
[TBL] [Abstract][Full Text] [Related]
13. Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast Tumors.
Shlensky D; Mirrielees JA; Zhao Z; Wang L; Mahajan A; Yu M; Sherer NM; Wilke LG; Xu W
PLoS One; 2015; 10(6):e0128143. PubMed ID: 26030442
[TBL] [Abstract][Full Text] [Related]
14. Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies.
Wan H; Huynh T; Pang S; Geng J; Vaccaro W; Poss MA; Trainor GL; Lorenzi MV; Gottardis M; Jayaraman L; Purandare AV
Bioorg Med Chem Lett; 2009 Sep; 19(17):5063-6. PubMed ID: 19632837
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: From underlying mechanisms to targeted therapeutics.
Jin W; Zhang J; Chen X; Yin S; Yu H; Gao F; Yao D
Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188916. PubMed ID: 37196782
[TBL] [Abstract][Full Text] [Related]
16. CARM1 arginine methyltransferase as a therapeutic target for cancer.
Santos M; Hwang JW; Bedford MT
J Biol Chem; 2023 Sep; 299(9):105124. PubMed ID: 37536629
[TBL] [Abstract][Full Text] [Related]
17. JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex.
Gao WW; Xiao RQ; Zhang WJ; Hu YR; Peng BL; Li WJ; He YH; Shen HF; Ding JC; Huang QX; Ye TY; Li Y; Liu ZY; Ding R; Rosenfeld MG; Liu W
Mol Cell; 2018 Apr; 70(2):340-357.e8. PubMed ID: 29628309
[TBL] [Abstract][Full Text] [Related]
18. Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1.
van Haren MJ; Marechal N; Troffer-Charlier N; Cianciulli A; Sbardella G; Cavarelli J; Martin NI
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3625-3630. PubMed ID: 28330993
[TBL] [Abstract][Full Text] [Related]
19. CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer.
Zhong XY; Yuan XM; Xu YY; Yin M; Yan WW; Zou SW; Wei LM; Lu HJ; Wang YP; Lei QY
Cell Rep; 2018 Sep; 24(12):3207-3223. PubMed ID: 30232003
[TBL] [Abstract][Full Text] [Related]
20. Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancer.
Inoue F; Sone K; Toyohara Y; Tanimoto S; Takahashi Y; Kusakabe M; Kukita A; Honjoh H; Nishijima A; Taguchi A; Miyamoto Y; Tanikawa M; Iriyama T; Uchino MM; Tsuruga T; Wada-Hiraike O; Oda K; Osuga Y
Biochem Biophys Res Commun; 2022 Apr; 601():123-128. PubMed ID: 35245741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
